SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
风魂剑主
Lv1
100 积分
2023-10-11 加入
最近求助
最近应助
互助留言
Co-occurring EGFR p.E709X mutation Mediates Primary Resistance to the Third-generation EGFR-TKIs in EGFR p.G719X-mutant Patients with Advanced NSCLC
1个月前
已完结
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C
2个月前
已完结
Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma
2个月前
已完结
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas
2个月前
已完结
Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy
2个月前
已完结
Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics
2个月前
已完结
Artificial intelligence–powered assessment of pathologic response to neoadjuvant atezolizumab in patients with non-small cell lung cancer: results from the LCMC3 study
2个月前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
2个月前
已完结
The Efficacy of Pemigatinib in Advanced NSCLC with FGFR Aberration: case report
2个月前
已完结
BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials
3个月前
已完结
没有进行任何应助
速度真快
2个月前
速度真快
2个月前
帮大忙了
2个月前
速度真快
2个月前
帮大忙了
5个月前
自己找到了【积分已退回】
5个月前
已找到文献【积分已退回】
5个月前
速度真快
5个月前
速度真快
6个月前
速度真快
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论